Outcomes in Pelvic Organ Prolapse Surgery in Women Using Chronic Antithrombotic Therapy

Rachel High, Alex Kavanagh, Rose Khavari, Julie Stewart, Danielle D. Antosh

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Introduction Chronic antithrombotic therapy is common among patients requiring surgery for pelvic organ prolapse because of age and comorbidities. The impact of chronic anticoagulation on postoperative complications in pelvic organ prolapse surgery has not been investigated. This study aims to determine if patients on chronic antithrombotic therapy are at increased risk for postoperative complications. Methods This retrospective cohort study included women having prolapse surgery from 2012 to 2015, identified by Current Procedural Terminology codes, excluding patients undergoing concomitant major nonurogynecologic procedures. Baseline characteristics were compared and all procedures performed, operative duration, estimated blood loss, and length of hospitalization. Complications (blood transfusion, intensive care unit admission, reoperation, readmission, hematoma, thromboembolic event, and infection) were compared in women on chronic antithrombotic therapy and controls. Logistic regression determined odds ratio (OR) for complications in patients on chronic antithrombotics. Complications were graded by the Clavien-Dindo classification. Results A total of 388 charts were reviewed, and 386 patients met inclusion criteria. Twenty-one of the 386 patients were on chronic antithrombotic therapy. Chronic antithrombotic therapy increased overall complications (OR, 6.8; P < 0.0005), blood transfusion (OR, 165; P < 0.001), intensive care unit admission (OR, 19.10; P < 0.004), hospital readmission (OR, 20.7; P < 0.0005), vaginal hematoma (OR, 554.1; P < 0.001), infection (OR, 22.44; P < 0.004), and complications that required specific additional follow-up (OR, 9.42; P < 0.0005). There were no thromboembolic events. Antithrombotic therapy did not significantly increase reoperation rates (OR, 3.8; P = 0.275). Findings were maintained when adjusting for covariates of age and body mass index. Conclusions Postoperative surgical complications after prolapse repair procedures are increased in patients who use chronic antithrombotic medication, the majority of cases are successfully managed conservatively.

Original languageEnglish (US)
Pages (from-to)372-376
Number of pages5
JournalFemale Pelvic Medicine and Reconstructive Surgery
Volume23
Issue number6
DOIs
StatePublished - Nov 1 2017

Keywords

  • Key Words pelvic organ prolapse
  • antithrombotic therapy
  • postoperative complications

ASJC Scopus subject areas

  • Surgery
  • Obstetrics and Gynecology
  • Urology

Fingerprint Dive into the research topics of 'Outcomes in Pelvic Organ Prolapse Surgery in Women Using Chronic Antithrombotic Therapy'. Together they form a unique fingerprint.

Cite this